These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 22926168)

  • 1. Trophic factors differentiate dopamine neurons vulnerable to Parkinson's disease.
    Reyes S; Fu Y; Double KL; Cottam V; Thompson LH; Kirik D; Paxinos G; Watson C; Cooper HM; Halliday GM
    Neurobiol Aging; 2013 Mar; 34(3):873-86. PubMed ID: 22926168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The transcription factor Pitx3 is expressed selectively in midbrain dopaminergic neurons susceptible to neurodegenerative stress.
    Luk KC; Rymar VV; van den Munckhof P; Nicolau S; Steriade C; Bifsha P; Drouin J; Sadikot AF
    J Neurochem; 2013 Jun; 125(6):932-43. PubMed ID: 23331067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of the homeobox gene Pitx3 in midbrain dopaminergic neurons.
    Korotkova TM; Ponomarenko AA; Haas HL; Sergeeva OA
    Eur J Neurosci; 2005 Sep; 22(6):1287-93. PubMed ID: 16190884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of immunoreactivity for deleted in colorectal cancer (DCC), the receptor for the guidance factor netrin-1, in ventral tier dopamine projection pathways in adult rodents.
    Osborne PB; Halliday GM; Cooper HM; Keast JR
    Neuroscience; 2005; 131(3):671-81. PubMed ID: 15730872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability in neuronal expression of dopamine receptors and transporters in the substantia nigra.
    Reyes S; Cottam V; Kirik D; Double KL; Halliday GM
    Mov Disord; 2013 Sep; 28(10):1351-9. PubMed ID: 23674405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender segregation in gene expression and vulnerability to oxidative stress induced injury in ventral mesencephalic cultures of dopamine neurons.
    Tao Q; Fan X; Li T; Tang Y; Yang D; Le W
    J Neurosci Res; 2012 Jan; 90(1):167-78. PubMed ID: 21919034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Otx2 expression is restricted to dopaminergic neurons of the ventral tegmental area in the adult brain.
    Di Salvio M; Di Giovannantonio LG; Omodei D; Acampora D; Simeone A
    Int J Dev Biol; 2010; 54(5):939-45. PubMed ID: 19924631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of Pitx3-Dependent Gene Regulatory Networks in Subsets of Midbrain Dopamine Neurons.
    Bifsha P; Balsalobre A; Drouin J
    Mol Neurobiol; 2017 Sep; 54(7):4921-4935. PubMed ID: 27514757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Otx2 selectively controls the neurogenesis of specific neuronal subtypes of the ventral tegmental area and compensates En1-dependent neuronal loss and MPTP vulnerability.
    Di Giovannantonio LG; Di Salvio M; Acampora D; Prakash N; Wurst W; Simeone A
    Dev Biol; 2013 Jan; 373(1):176-83. PubMed ID: 23117062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and cellular alterations in the Pitx3-deficient midbrain dopaminergic system.
    Smits SM; Mathon DS; Burbach JP; Ramakers GM; Smidt MP
    Mol Cell Neurosci; 2005 Nov; 30(3):352-63. PubMed ID: 16140547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neuregulin receptor, ErbB4, is not required for normal development and adult maintenance of the substantia nigra pars compacta.
    Thuret S; Alavian KN; Gassmann M; Lloyd CK; Smits SM; Smidt MP; Klein R; Dyck RH; Simon HH
    J Neurochem; 2004 Dec; 91(6):1302-11. PubMed ID: 15584907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cytoarchitectonic and chemoarchitectonic analysis of the dopamine cell groups in the substantia nigra, ventral tegmental area, and retrorubral field in the mouse.
    Fu Y; Yuan Y; Halliday G; Rusznák Z; Watson C; Paxinos G
    Brain Struct Funct; 2012 Apr; 217(2):591-612. PubMed ID: 21935672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pluripotent stem cell derived dopaminergic subpopulations model the selective neuron degeneration in Parkinson's disease.
    Oosterveen T; Garção P; Moles-Garcia E; Soleilhavoup C; Travaglio M; Sheraz S; Peltrini R; Patrick K; Labas V; Combes-Soia L; Marklund U; Hohenstein P; Panman L
    Stem Cell Reports; 2021 Nov; 16(11):2718-2735. PubMed ID: 34678205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental origin and fate of meso-diencephalic dopamine neurons.
    Smits SM; Burbach JP; Smidt MP
    Prog Neurobiol; 2006 Jan; 78(1):1-16. PubMed ID: 16414173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profiling of rat midbrain dopamine neurons: implications for selective vulnerability in parkinsonism.
    Greene JG; Dingledine R; Greenamyre JT
    Neurobiol Dis; 2005 Feb; 18(1):19-31. PubMed ID: 15649693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease?
    Chu Y; Kordower JH
    Neurobiol Dis; 2007 Jan; 25(1):134-49. PubMed ID: 17055279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homeobox gene Pitx3 and its role in the development of dopamine neurons of the substantia nigra.
    Smidt MP; Smits SM; Burbach JP
    Cell Tissue Res; 2004 Oct; 318(1):35-43. PubMed ID: 15300495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GIRK2 expression in dopamine neurons of the substantia nigra and ventral tegmental area.
    Reyes S; Fu Y; Double K; Thompson L; Kirik D; Paxinos G; Halliday GM
    J Comp Neurol; 2012 Aug; 520(12):2591-607. PubMed ID: 22252428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine transporter messenger RNA in Parkinson's disease and control substantia nigra neurons.
    Uhl GR; Walther D; Mash D; Faucheux B; Javoy-Agid F
    Ann Neurol; 1994 Apr; 35(4):494-8. PubMed ID: 8154880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fate of midbrain dopaminergic neurons controlled by the engrailed genes.
    Simon HH; Saueressig H; Wurst W; Goulding MD; O'Leary DD
    J Neurosci; 2001 May; 21(9):3126-34. PubMed ID: 11312297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.